Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000321182 | SCV000345753 | benign | not specified | 2016-09-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000321182 | SCV000529241 | benign | not specified | 2016-11-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001082559 | SCV000650899 | benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000711675 | SCV000842062 | benign | not provided | 2018-08-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002392818 | SCV002702721 | benign | Cardiovascular phenotype | 2019-03-05 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000711675 | SCV004010718 | benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | FLNC: BP4, BP7, BS1, BS2 |
CHEO Genetics Diagnostic Laboratory, |
RCV003486812 | SCV004240611 | benign | Cardiomyopathy | 2023-06-07 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000321182 | SCV004241490 | benign | not specified | 2023-12-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003957527 | SCV004769464 | benign | FLNC-related disorder | 2019-07-19 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000321182 | SCV001917554 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000711675 | SCV001931130 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000321182 | SCV001957218 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000711675 | SCV001973235 | likely benign | not provided | no assertion criteria provided | clinical testing |